ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,932Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 247

$681K Total Retail Price of All Prescriptions

Rank: 14 out of 247

248 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 248 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 248 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 6,244 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
FUROSEMIDE 307 241 1 5
SIMVASTATIN 280 213 2 1
LISINOPRIL 256 165 3 2
OMEPRAZOLE 236 206 4 4
METOPROLOL SUCCINATE 185 175 5 14
LEVOTHYROXINE SODIUM 181 132 6 3
AMLODIPINE BESYLATE 178 159 7 6
METOPROLOL TARTRATE 177 152 8 7
ATORVASTATIN CALCIUM 152 130 9 8
METFORMIN HCL 151 110 10 12
WARFARIN SODIUM 149 145 11 13
CRESTOR 141 108 12 30
KLOR-CON M20 123 104 13 44
ADVAIR DISKUS 123 103 13 18
GLIPIZIDE 112 82 15 43
HYDROCHLOROTHIAZIDE 107 79 16 9
ISOSORBIDE MONONITRATE ER 103 98 17 40
LOSARTAN POTASSIUM 100 98 18 15
HYDROCODONE-ACETAMINOPHEN 97 78 S3 19 11
ATENOLOL 93 85 20 10
PREDNISONE 93 67 20 21
DIOVAN 89 77 22 38
DONEPEZIL HCL 88 88 23 35
PANTOPRAZOLE SODIUM 84 76 24 19
ESCITALOPRAM OXALATE 81 72 25 65
GABAPENTIN 80 65 26 17
JANTOVEN 79 79 27 76
RANITIDINE HCL 77 62 28 34
NYSTATIN 75 69 29 129
NEXIUM 71 61 30 42
JANUVIA 68 64 31 56
PROAIR HFA 65 41 32 29
DILTIAZEM 24HR ER 58 58 33 171
TRICOR 57 52 34 140
POTASSIUM CHLORIDE 57 45 34 36
COMBIVENT 55 41 36 63
TAMSULOSIN HCL 54 50 37 31
BENICAR 54 44 37 116
SPIRONOLACTONE 53 47 39 53
AZITHROMYCIN 53 38 39 48
DOXAZOSIN MESYLATE 53 39 39 57
CYCLOBENZAPRINE HCL 52 25 R 42 54
ALLOPURINOL 51 50 43 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.